Gene Query: CRBN

Dataset Description Geneva Score
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 29.77
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 29.77
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 17.04
Transcriptomic profiling of human peripheral blood-derived mast cells 17.04
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 15.84
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 15.52
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 15.52
mRNA expression profile of Lymphocytes 15.03
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 14.47
DART-seq: an antibody-free method for global m6A detection 14.3
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 13.42
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 12.58
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 12.43
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 11.27
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.21
LncRNA expression profiling of ischemic stroke patients 11.21
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 10.67
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 10.47
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 10.47
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.47
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 9.87
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 9.78
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 9.67
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 9.6
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 9.37
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 9.37
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 9.15
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 8.92
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 8.72
Endothelial gene expression analysis 8.72
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.46
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.32
DRB/GRO-Seq -/+ UV 8.31
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 8.18
CROP-Seq in Primary Human T Cells 8.13
Stem and effector CD8 T-cells from human cancers 8.1
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 8.05
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 7.83
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 7.55
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.49
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.48
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 7.47
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 7.43
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 7.43
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 7.4
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 7.34
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.26
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 7.16
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 7.09
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 6.9
Cleavage Factor Im as a key regulator of 3’ UTR length 6.83
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.82
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.71
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 6.69
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 6.66
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 6.66
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 6.66
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.6
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.59
SRSF2 mutations impair hematopoiesis and alter exon recognition 6.53
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.45
AR-independent prostate cancer is sustained through FGF signaling 6.44
Transcriptome analysis of CNS leukemia 6.42
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 6.42
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 6.41
single cell RNA-seq from GM12878 (ENCSR673UIY) 6.4
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.26
LNCaP treated with iBET 6.23
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 6.19
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 6.17
Role for citron kinase in prostate cancer growth 6.15
HNRNPL and its RNA Targets in Prostate Cancer 6.15
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 6.15
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.11
Control of prostate tumour growth by the long non-coding RNA GHSROS 6.1
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 6.01
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.99
Transciptomic profiling of human fetal lung samples 5.94
Identification of renal resident macrophages across species 5.89
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 5.79
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.76
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.76
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 5.75
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.74
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 5.73
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 5.72
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 5.68
Electronic cigarettes 5.68
Dtx3L and Androgen Signaling in Prostate Cancer 5.66
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 5.62
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 5.57
Transcriptome of activated human and mouse MAIT cells 5.44
Regulation of protein translation during mitosis 5.39
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.38
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 5.37
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 5.36
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 5.36
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.27
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 5.19
The regulartory role of ZCCHC24 in splicing machinery 5.17
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.14
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 5.12
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 5.05
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.01
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.0
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.99
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 4.98
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.97
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.95
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 4.95
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 4.95
Global Mapping of Human RNA-RNA Interactions 4.92
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 4.85
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.83
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 4.82
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.76
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 4.73
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 4.67
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.59
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.52
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 4.5
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 4.49
Patient-derived luminal breast cancer xenografts with progestins 4.49
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 4.49
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 4.49
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.43
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.38
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.33
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.32
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 4.32
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 4.31
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.31
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.31
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.3
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.25
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 4.25
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 4.25
Expression level comparison under dividing and quiescent states in human primary fibroblasts 4.16
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 4.14
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 4.12
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 4.11
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.1
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 4.07
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.04
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.02
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 4.01
Uridylation by TUT4 and TUT7 marks mRNA for degradation 3.99
RNA-seq of YB5 cells treated with Proscillaridin A 3.97
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 3.94
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 3.93
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.91
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.91
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.91
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.89
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.88
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 3.87
scRNASeq analysis of cycling cardiomyocytes 3.86
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 3.86
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.85
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 3.83
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.82
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.79
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.78
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.77
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.77
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.76
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 3.74
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.73
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.72
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.72
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 3.72
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 3.72
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 3.69
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.68
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 3.66
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 3.65
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 3.63
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 3.63
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.62
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 3.61
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.6
Paxillin regulates genomic networks in prostate cancer [PC3] 3.6
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.59
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 3.59
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.53
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 3.52
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.49
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.49
RNA-seq differential expression studies: more sequence, or more replication? 3.48
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.47
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.47
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.45
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.45
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.43
Characterization of human ILC2 subsets 3.41
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.4
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.39
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.37
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.37
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.37
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.36
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.35
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.34
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 3.33
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.32
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.32
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.31
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 3.3
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 3.3
CircRNAome diversity in human mature B-cells, T-cells and monocytes 3.24
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.23
RNA sequencing of primary human platelets and in vitro cell lines 3.21
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 3.2
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.18
Statins modulate endothelial transcriptional profile by inhibiting EZH2 3.18
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 3.18
Nonpregnant and term pregnant human myometrial tissues 3.18
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.17
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 3.16
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 3.16
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.15
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.15
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.13
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.13
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.12
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 3.09
The conserved transcriptional landscapes in human spermatogenesis 3.07
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.06
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.02
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.01
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.0
Chromatin landscape of human visceral and subcutaneous adipocytes 2.99
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 2.98
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.98
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 2.93
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.93
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 2.89
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.88
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 2.84
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 2.8
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.79
Transcription control by the ENL YEATS domain in acute leukemia 2.79
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.79
ETV7 and interferon response 2.78
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.78
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 2.76
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 2.75
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 2.75
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.73
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.71
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.71
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.67
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 2.65
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.62
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.62
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.6
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.59
Gene expression in GBM with Cav3.2 inhibition 2.56
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.53
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.51
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.5
Transcriptional landscape changes during human embryonic stem cell derivation 2.5
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 2.46
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 2.45
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.44
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.43
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.43
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.41
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 2.4
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 2.39
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.39
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 2.32
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.31
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.3
RNA-seq data 2.27
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 2.27
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.27
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.27
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.26
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 2.26
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.2
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.2
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.19
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.17
O-glcnAc reprograms cellular energetics 2.15
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.13
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.13
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 2.12
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 2.12
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.1
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.07
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.05
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.05
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.05
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.03
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.03
Common inflammatory pathways between NEC and Crohn's disease 1.99
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 1.99
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 1.99
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.97
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 1.92
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.92
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.91
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.87
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.87
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.86
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.86
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.86
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.85
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.84
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.84
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.82
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.81
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.8
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.79
In vitro modeling of human germ cell development using pluripotent stem cells 1.79
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.78
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.77
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.76
LIN28A Over-expression RNAseq 1.75
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.74
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.73
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.73
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.73
RNAseq in Alzheimer's Disease patients 1.72
Systematic discovery of endogenous human ribonucleoprotein complexes 1.71
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.71
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.69
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.69
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.67
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.67
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.66
Deep RNA sequencing of the human placental transcriptome 1.64
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.6
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.57
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.56
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 1.55
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.54
Proliferation-correlated expression 1.54
The contribution of Alu exons to the human proteome 1.49
SLAM-seq for K562 endogenous mRNA decay 1.49
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.48
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 1.48
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 1.48
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.47
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.46
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.46
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.45
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.45
Interaction between mitoNEET and NAF-1 in cancer cells 1.43
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.42
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.41
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.41
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.4
Human Treg IL-12 stimulation 1.39
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.35
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.35
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.33
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.32
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.32
Morphological and molecular characterization of human dermal lymphatic collectors 1.31
Effect of PRDM11 depletion in U2932 cells 1.31
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.31
Functional significance of the HIV-1 Tat signature amino acid residues 1.3
Measure transcript integrity using RNA-seq data 1.3
Gene expression changes due to PARP knockdown in human cells 1.3
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.3
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.29
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.29
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.25
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.25
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.24
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.23
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.21
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.21
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.2
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.2
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.2
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.19
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.17
Identification of a LIF-responsive replication-competent human β cell 1.16
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.15
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.15
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.14
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.11
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.1
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.09
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.08
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.05
Discovering human diabetes-risk gene function with genetics and physiological assays 1.05
The transcriptome and chromatin accessbility landscape of mammalian germline 1.0
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.99
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.96
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.96
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.96
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.95
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.94
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 0.93
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.92
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.9
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.88
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.85
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.85
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.84
Unique features and clinical importance of acute alloreactive immune responses 0.84
RNA-seq of IL-4 stimulated human keratinocytes 0.84
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.84
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.83
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.83
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.83
Interphase condensins regulate ligand-depedent enhancer activation 0.83
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.81
SF3B1 Degron knockdown RNA-seq 0.77
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.75
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.75
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.75
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.74
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.7
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.69
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.64
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.63
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.63
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.61
RNA-seq of primary patient AML samples 0.6
Human Tfh cell RNA bulk sequencing 0.6
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.59
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.59
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.58
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.58
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.57
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 0.55
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.54
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 0.54
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.53
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.5
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.48
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.47
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.47
High-resolution comparative analysis of great ape genomes 0.46
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.45
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.44
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.43
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.42
Analyses of T-ALL (COG study) 0.42
RNA sequencing of T-ALL (COG study) 0.42
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.41
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.39
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.39
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.38
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.38
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.38
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.35
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.35
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.35
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.35
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.35
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.3
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.29
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.28
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.28
HEK293 TFAM Knockout Expression Study 0.27
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.27
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.27
Aging-associated patterns in the expression of human endogenous retroviruses 0.25
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.23
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.23
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.23
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.23
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.22
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.22
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.19
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.19
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.17
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.16
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.16
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.16
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.14
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.12
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.11
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.1
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.1
naive T cell heterogeneity after neonatal thymectomy 0.09
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.09
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.08
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.08
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.06
Role of FGFR1 in neuronal devlopment 0.06
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.06
Modeling Human Cancer-induced Cachexia (Human) 0.06
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.05
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.04
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.03
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.03
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.03
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.02
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation